More than 50 lakh healthcare, frontline workers, 60 years plus-given Precaution Dose: Health Minister Medical Dialogues Bureau19 Jan 2022 9:30 AM ISTNew Delhi: Union Health Minister Mansukh Mandaviya on Tuesday said over 50 lakh healthcare and frontline workers and citizens aged 60 years or above...
Pfizer oral COVID pill Paxlovid approved in Canada Dr. Divya Colin18 Jan 2022 4:33 PM ISTNew Delhi: Canada on Monday approved Pfizer Inc's oral antiviral treatment for mild to moderate cases of COVID-19 in adults, but said global supply...
India's Gennova developing Omicron-specific COVID-19 vaccine Dr. Divya Colin18 Jan 2022 10:15 AM ISTNew Delhi: India's Gennova Biopharmaceuticals is working on an Omicron-specific mRNA COVID-19 vaccine candidate, it told Reuters on Monday, after a...
4th mRNA vaccine against COVID 19 approved for kidney transplant patients Dr. Nandita Mohan15 Jan 2022 4:25 PM ISTCovid 19 is known to cause multiorgan failure in most of its patients, Kidney trasplants have also increased their commplications are directly...
JnJ COVID booster 85 percent effective against Omicron hospitalisation: SAMRC Ruchika Sharma15 Jan 2022 11:00 AM ISTJohannesburg: A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for...
Covishield 3rd dose increases antibody response against Omicron: Study Roshni Dhar14 Jan 2022 5:38 PM ISTA third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron variant,...
Fourth dose of mRNA-based vaccine may be warranted in some kidney transplant recipients Hina Zahid14 Jan 2022 8:15 AM ISTKidney transplant recipients receiving immunosuppressive drugs have impaired immune responses to messenger RNA (mRNA) COVID-19 vaccines ....
Moderna to report COVID vaccine data for children aged 2-5 in March Ruchika Sharma13 Jan 2022 4:35 PM ISTNew Delhi: Moderna Inc said it expects to report data from its Covid-19 vaccine trial in children aged between 2 to 5 years in March."If the data is...
Covishield 3rd dose increases antibody response against Omicron, says Study MD Bureau13 Jan 2022 3:52 PM ISTLondon: A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron...
Covaxin booster dose shows neutralising effect on Omicron, Delta variants, states Study Ruchika Sharma13 Jan 2022 1:08 PM ISTNew Delhi: Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta...
USFDA warns against rare bleeding risk of JnJ COVID vaccine Ruchika Sharma12 Jan 2022 4:15 PM ISTNew Delhi: The U.S. Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson's COVID-19 vaccine to include a rare...
JnJ Single shot vaccine protects against breakthrough COVID-19 for up to 6 months: Study Roshni Dhar12 Jan 2022 11:47 AM ISTJohnson & Johnson said on Thursday that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough infections and...
